S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
Log in

NASDAQ:RKDAArcadia Biosciences Stock Price, Forecast & News

$3.78
+0.06 (+1.61 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.65
Now: $3.78
$4.05
50-Day Range
$3.49
MA: $3.79
$4.37
52-Week Range
$2.30
Now: $3.78
$10.20
Volume653,453 shs
Average Volume220,083 shs
Market Capitalization$37.97 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.8
Arcadia Biosciences, Inc., an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits. It also provides nutritional oils comprising gamma linolenic acid safflower oil to manufacturers of dietary and nutritional supplements, medical foods, dog food, and other products under the SONOVA brand; and arachidonic acid safflower oil that is used as an ingredient in infant nutrition products. In addition, the company has various programs under development comprising fiber resistant starch wheat, whole grain flour, and reduced gluten wheat programs. Arcadia Biosciences, Inc. has strategic collaborations with Dow AgroSciences and Ardent Mills LLC to develop and commercialize wheat varieties. The company was founded in 2002 and is headquartered in Davis, California.
Read More
Arcadia Biosciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.35 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
Current SymbolNASDAQ:RKDA
CUSIPN/A
Phone530-756-7077

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.17 million
Book Value$0.96 per share

Profitability

Net Income$-28,810,000.00
Net Margins-1,035.38%

Miscellaneous

Employees44
Market Cap$37.97 million
Next Earnings Date8/13/2020 (Confirmed)
OptionableNot Optionable
$3.78
+0.06 (+1.61 %)
(As of 08/11/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RKDA News and Ratings via Email

Sign-up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Arcadia Biosciences (NASDAQ:RKDA) Frequently Asked Questions

How has Arcadia Biosciences' stock been impacted by COVID-19 (Coronavirus)?

Arcadia Biosciences' stock was trading at $3.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RKDA stock has increased by 19.2% and is now trading at $3.78.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Arcadia Biosciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcadia Biosciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Arcadia Biosciences
.

When is Arcadia Biosciences' next earnings date?

Arcadia Biosciences is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020.
View our earnings forecast for Arcadia Biosciences
.

How can I listen to Arcadia Biosciences' earnings call?

Arcadia Biosciences will be holding an earnings conference call on Thursday, August 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Arcadia Biosciences' earnings last quarter?

Arcadia Biosciences Inc (NASDAQ:RKDA) posted its quarterly earnings data on Wednesday, May, 13th. The basic materials company reported $0.29 EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.55) by $0.84. The basic materials company had revenue of $0.31 million for the quarter, compared to analysts' expectations of $0.60 million. Arcadia Biosciences had a negative return on equity of 180.70% and a negative net margin of 1,035.38%.
View Arcadia Biosciences' earnings history
.

When did Arcadia Biosciences' stock split? How did Arcadia Biosciences' stock split work?

Arcadia Biosciences shares reverse split on the morning of Wednesday, January 24th 2018. The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 23rd 2018. An investor that had 100 shares of Arcadia Biosciences stock prior to the reverse split would have 5 shares after the split.

What price target have analysts set for RKDA?

2 equities research analysts have issued 12 month target prices for Arcadia Biosciences' stock. Their forecasts range from $14.00 to $16.00. On average, they expect Arcadia Biosciences' share price to reach $15.00 in the next twelve months. This suggests a possible upside of 296.8% from the stock's current price.
View analysts' price targets for Arcadia Biosciences
.

Has Arcadia Biosciences been receiving favorable news coverage?

Media headlines about RKDA stock have been trending neutral recently, InfoTrie reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Arcadia Biosciences earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned news stories about the basic materials company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about Arcadia Biosciences
.

Are investors shorting Arcadia Biosciences?

Arcadia Biosciences saw a decline in short interest in the month of February. As of February 28th, there was short interest totaling 610,100 shares, a decline of 18.6% from the February 13th total of 749,600 shares. Based on an average daily volume of 256,800 shares, the short-interest ratio is currently 2.4 days.
View Arcadia Biosciences' Short Interest
.

Who are some of Arcadia Biosciences' key competitors?

What other stocks do shareholders of Arcadia Biosciences own?

Who are Arcadia Biosciences' key executives?

Arcadia Biosciences' management team includes the following people:
  • Mr. Rajendra Ketkar, Pres, CEO & Director (Age 65)
  • Mr. Matthew T. Plavan, CFO, Sec. & Pres of Arcadia Specialty Genomics (Age 55)
  • Ms. Sarah Reiter, Chief Commercial Officer (Age 47)
  • Dr. Randy Shultz Ph.D., Head of R&D
  • Dr. Zhongjin Lu Ph.D., Director of Product Devel. (Age 53)

When did Arcadia Biosciences IPO?

(RKDA) raised $66 million in an IPO on Friday, May 15th 2015. The company issued 8,200,000 shares at $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray acted as the underwriters for the IPO.

What is Arcadia Biosciences' stock symbol?

Arcadia Biosciences trades on the NASDAQ under the ticker symbol "RKDA."

Who are Arcadia Biosciences' major shareholders?

Arcadia Biosciences' stock is owned by a number of institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.30%) and HighTower Advisors LLC (0.13%). Company insiders that own Arcadia Biosciences stock include Kevin Comcowich, Lilian Shackelford Murray, Matthew T Plavan and Sarah Reiter.
View institutional ownership trends for Arcadia Biosciences
.

Which institutional investors are buying Arcadia Biosciences stock?

RKDA stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC, and HighTower Advisors LLC. Company insiders that have bought Arcadia Biosciences stock in the last two years include Kevin Comcowich, Lilian Shackelford Murray, Matthew T Plavan, and Sarah Reiter.
View insider buying and selling activity for Arcadia Biosciences
.

How do I buy shares of Arcadia Biosciences?

Shares of RKDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Arcadia Biosciences' stock price today?

One share of RKDA stock can currently be purchased for approximately $3.78.

How big of a company is Arcadia Biosciences?

Arcadia Biosciences has a market capitalization of $37.97 million and generates $1.17 million in revenue each year. The basic materials company earns $-28,810,000.00 in net income (profit) each year or ($3.37) on an earnings per share basis. Arcadia Biosciences employs 44 workers across the globe.

What is Arcadia Biosciences' official website?

The official website for Arcadia Biosciences is www.arcadiabio.com.

How can I contact Arcadia Biosciences?

Arcadia Biosciences' mailing address is 202 COUSTEAU PLACE SUITE 105, DAVIS CA, 85018. The basic materials company can be reached via phone at 530-756-7077 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.